After sharing his story of a missed diagnosis and family silence, Gregory Jacob Jr.'s advocacy journey takes him from the ...

Androgen receptor pathway inhibitors (ARPIs) in combination with androgen deprivation therapy (ADT) represent the foundation ...

Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

Fresh from a European cancer conference that was all about antibody-drug conjugates (ADCs), GSK has turned to French biotech ...

Enlarged prostate is a common non-cancerous condition that affects older men but many patients wait months for care.

Roberto Correa, a prostate cancer survivor, has found life-changing relief from incontinence thanks to new technology.

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.

A newly uncovered mechanism thought to be a weakness of prostate cancer cells could inspire a new and improved targeted treatment for the disease. International research led by Flinders University in ...

WASHINGTON (AP) — Former President Joe Biden is receiving radiation and hormone therapy as part of a new phase of treating the aggressive form of prostate cancer he was diagnosed with after leaving ...